Providers/Grant Support
This activity is supported by an independent education grant from Lilly.
Credits Available
This activity does not offer credit.
Target Audience
This activity is designed to meet the educational needs of Imaging physicians, including Nuclear Medicine Physicians, Radiologists, Neuroradiologists, Radiology Physician Assistants, Imaging Residents. It is also suitable for Neurologists.
Program Overview
As the landscape of Alzheimer’s disease continues to evolve, PET imaging is playing an increasingly critical role in early and accurate diagnosis, disease staging, and treatment decision-making. But how can nuclear medicine and radiology physicians effectively integrate PET imaging into clinical practice while navigating regional variations, emerging tracers, and evolving guidelines?
This activity will cover the latest insights, practical strategies, and real-world case studies on PET imaging in Alzheimer’s disease. Featuring leading experts from Europe, Asia, and the USA, this program will provide a global perspective on best practices, challenges, and decision-making tools to optimize patient care.
Put your decision-making and interpretation skills into practice in a simulated environment. Presented with different patient characteristics, you will be challenged to choose the optimal tracer, accurately interpret the results, and advise on next steps.
Learning Objectives
Upon completion of this activity, participants should be better able to:
- Integrate best practice for the selection, interpretation, and reporting of PET biomarkers in the context of your local clinical practice
- Incorporate optimal communication and reporting methods to enhance interdisciplinary working and patient relationships
Faculty
Dr Tanyaluck Thientunyakit
Associate Professor, Radiology
Faculty of Medicine Siriraj Hospital, Bangkok, Thailand
Dr. Tanyaluck Thientunyakit is an Associate Professor in Nuclear Medicine. She got the Thai Board of Nuclear Medicine in 2004 and the Fellow of the Asian Nuclear Medicine Board in 2017. She is President of Quality Development in the Department of Radiology, Faculty of Medicine Siriraj Hospital, Mahidol University in Bangkok, Thailand. She is also The National Hybrid Imaging Ambassador to Thailand for the European Society for Hybrid, Molecular, and Translation Imaging, Board member of the Brain Imaging Council, Society of Nuclear Medicine Molecular Imaging, and Faculty Member of Asian Nuclear Medicine Board.
Dr. Thientunyakit has had experiences in clinical services, teachings, administration, research grants, journal reviews, and coordination for scientific activities at both national and international levels. Her special interests and publications are in Nuclear Medicine Applications in Oncology, Neurology, Thyroid Diseases, and Routine-to-Research for Quality Development in Radiology and Nuclear Medicine Services. She was an invited speaker at several academic conferences in Asian countries. She has collaborated with the IAEA and RCARO through many national and international projects, including collaborative research projects in neurology and cardiology. She received awards from National and International organizations, including the Ministry of Public Health, Thailand, RCARO, WFNMB, ECR, and SNMMI, for her academic and research activities.
Disclosures of Conflicts of Interest
Dr Tanyaluck Thientunyakit
Disclosures
Research grant from GC Healthcare Co, Thailand.
Instructions for Participation
There are no fees for participating in this enduring activity. Read the information and faculty disclosures, participate in this online activity, and submit the evaluation form.
Disclosure of Unlabeled Use
Faculty participating in any CME activity are required to disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.
Disclaimer
This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.
Contact Information
For questions please contact [email protected]